The University of Wisconsin–Madison and Immuto Scientific are exploring new therapeutic targets in colorectal cancer, WKOW reports.
The collaboration aims to use Immuto’s AI platform to discover novel treatments for solid colorectal cancer tumors.
“Our work with Dr. (Dustin) Deming and the University of Wisconsin-Madison represents an exceptional opportunity to study colorectal cancer in a clinically relevant form,” Faraz A. Choudhury, co-founder and CEO of Immuto Scientific, told WKOW.
Both collaborators say the work is a big step in advancing cancer treatment options.
